Sofinnova Investments, Inc. Q2 2024 Filing
Filed August 9, 2024
Portfolio Value
$1.9B
Holdings
75
Report Date
Q2 2024
Filing Type
13F-HR
All Holdings (75 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NDQInvesco QQQ TR | 400,000 | $191.6T | 9959837.19% | Put |
| 2 | NTRANatera Inc | 1,550,280 | $167.9T | 8724800.59% | |
| 3 | EWEdwards Lifesciences Corp | 1,224,225 | $113.1T | 5876912.15% | Put |
| 4 | VERAVera Therapeutics Inc | 2,793,987 | $101.1T | 5253514.77% | |
| 5 | ASNDAscendis Pharma A/S | 734,284 | $100.1T | 5204413.13% | |
| 6 | NVONovo-Nordisk A S | 649,541 | $92.7T | 4818471.26% | |
| 7 | SYKStryker Corporation | 193,084 | $65.7T | 3414298.08% | |
| 8 | AZNAstraZeneca PLC | 801,417 | $62.5T | 3248287.68% | |
| 9 | ISRGIntuitive Surgical Inc | 137,217 | $61.0T | 3172331.21% | Put |
| 10 | DYNDyne Therapeutics Inc | 1,625,703 | $57.4T | 2981603.43% | |
| 11 | AFWAlign Technology Inc | 218,524 | $52.8T | 2741873.32% | |
| 12 | ALNYAlnylam Pharmaceuticals Inc | 197,929 | $48.1T | 2499612.66% | Call |
| 13 | RAPPRapport Therapeutics Inc | 1,951,562 | $45.4T | 2359114.80% | |
| 14 | SNDXSyndax Pharmaceuticals Inc | 2,153,669 | $44.2T | 2297867.18% | |
| 15 | ELANElanco Animal Health Inc | 2,864,250 | $41.3T | 2147999.97% | |
| 16 | ABTAbbott Labs | 390,200 | $40.5T | 2107179.93% | Call |
| 17 | IDYAIDEAYA Biosciences Inc | 1,151,528 | $40.4T | 2101175.57% | |
| 18 | TGTXTG Therapeutics Inc | 1,861,277 | $33.1T | 1720853.79% | |
| 19 | AVBPArrivent BioPharma Inc | 1,696,752 | $31.5T | 1635758.94% | |
| 20 | IDXXIDEXX Labs Inc | 63,862 | $31.1T | 1616988.02% | |
| 21 | SRPTSarepta Therapeutics Inc | 195,852 | $30.9T | 1608207.60% | |
| 22 | YMABUSDY-mAbs Therapeutics Inc | 2,194,278 | $26.5T | 1377576.07% | |
| 23 | AXSMAxsome Therapeutics Inc | 310,198 | $25.0T | 1297752.54% | |
| 24 | COGTCogent Biosciences Inc | 2,773,286 | $23.4T | 1215008.30% | |
| 25 | XBISpdr Ser Tr | 250,000 | $23.2T | 1204546.59% | Put |
| 26 | SLNOSoleno Therapeutics Inc | 554,359 | $22.6T | 1175461.13% | |
| 27 | YB4PSavara Inc | 5,508,918 | $22.2T | 1153794.26% | Put |
| 28 | TCE2Celldex Therapeutics Inc | 547,707 | $20.3T | 1053475.37% | |
| 29 | ROIVRoivant Sciences Ltd | 1,868,412 | $19.7T | 1026371.66% | |
| 30 | ESTAEstablishment Labs Hldgs Inc | 429,244 | $19.5T | 1013676.92% | |
| 31 | INZYInozyme Pharma Inc | 4,280,308 | $19.1T | 992126.16% | |
| 32 | RVMDRevolution Medicines Inc | 455,099 | $17.7T | 917923.59% | |
| 33 | KURAKura Oncology Inc | 825,243 | $17.0T | 883070.14% | |
| 34 | IM8NInsmed Inc | 227,747 | $15.3T | 793020.62% | |
| 35 | BSXBoston Scientific Corp | 171,080 | $13.2T | 684704.82% | |
| 36 | MDGLMadrigal Pharmaceuticals Inc | 44,417 | $12.4T | 646714.16% | |
| 37 | PODDInsulet Corp | 60,967 | $12.3T | 639400.56% | |
| 38 | PHVSPharvaris N V | 601,534 | $11.3T | 587726.18% | |
| 39 | AXNX*Axonics Inc | 150,490 | $10.1T | 525808.71% | |
| 40 | IMTXImmatics N.V | 796,704 | $9.3T | 481127.43% | |
| 41 | CABACabaletta Bio Inc | 1,220,400 | $9.1T | 474417.62% | |
| 42 | PEPGPepGen Inc | 561,128 | $9.0T | 465427.29% | |
| 43 | EWTXEdgewise Therapeutics Inc | 475,691 | $8.6T | 445241.53% | |
| 44 | IMNMImmunome Inc | 655,680 | $7.9T | 412319.92% | |
| 45 | EXASExact Sciences Corp | 181,828 | $7.7T | 399249.60% | |
| 46 | NARIUSDInari Med Inc | 155,838 | $7.5T | 389965.95% | |
| 47 | DC4Dexcom Inc | 61,494 | $7.0T | 362348.30% | |
| 48 | INBXInhibrx Biosciences Inc | 463,315 | $6.6T | 341195.47% | |
| 49 | SP4PAchieve Life Sciences Inc | 1,388,372 | $6.5T | 339125.69% | |
| 50 | WATWaters Corp | 21,804 | $6.3T | 328753.83% | |
| 51 | AVTEAerovate Therapeutics Inc | 3,758,686 | $6.2T | 324265.81% | |
| 52 | FDMT4D Molecular Therapeutics Inc | 271,155 | $5.7T | 295792.42% | |
| 53 | MRNS*Marinus Pharmaceuticals Inc | 4,256,276 | $5.0T | 258805.00% | Call |
| 54 | NXTCNextcure Inc | 2,671,856 | $4.2T | 220783.79% | |
| 55 | ERASErasca Inc | 1,699,528 | $4.0T | 208447.81% | |
| 56 | PAHCPhibro Animal Health Corp | 237,009 | $4.0T | 206564.14% | |
| 57 | BAXBaxter Intl Inc | 117,769 | $3.9T | 204731.24% | |
| 58 | AVTRAvantor Inc | 141,045 | $3.0T | 155399.84% | |
| 59 | TFXTeleflex Incorporated | 13,649 | $2.9T | 149196.64% | |
| 60 | 3M4Masimo Corp | 20,161 | $2.5T | 131957.08% | |
| 61 | BOLT1EURBolt Biotherapeutics Inc | 2,754,437 | $2.1T | 107362.14% | |
| 62 | INSPInspire Med Sys Inc | 10,000 | $1.3T | 69552.14% | |
| 63 | IRONDisc Medicine Inc | 29,256 | $1.3T | 68526.66% | |
| 64 | CATXPerspective Therapeutics Inc | 132,089 | $1.3T | 68441.37% | |
| 65 | ZBHZimmer Biomet Holdings Inc | 10,630 | $1.2T | 59957.03% | |
| 66 | AMLXAmylyx Pharmaceuticals Inc | 599,691 | $1.1T | 59215.88% | Put |
| 67 | LIVNLivaNova PLC | 20,602 | $1.1T | 58695.60% | |
| 68 | IMTXImmatics N.V | 348,731 | $932.9B | 48480.95% | |
| 69 | RNAAvidity Biosciences Inc | 21,425 | $875.2B | 45485.17% | |
| 70 | —Ikena Oncology Inc | 382,616 | $631.3B | 32809.82% | |
| 71 | CATBUSDAstria Therapeutics Inc | 60,692 | $552.3B | 28703.16% | |
| 72 | PDSBPDS Biotechnology Corp | 142,635 | $417.9B | 21719.57% | |
| 73 | LUNGPulmonx Corp | 60,246 | $382.0B | 19850.66% | |
| 74 | KYTXKyverna Therapeutics Inc | 47,850 | $358.9B | 18650.92% | |
| 75 | GPCRStructure Therapeutics Inc | 8,915 | $350.1B | 18194.46% |